Home > Healthcare > Medical Devices > Diagnostic Devices > STD Diagnostics Market

STD Diagnostics Market Size

Report ID: GMI8292
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

STD Diagnostics Market Size

STD Diagnostics Market size was valued at USD 13.8 billion in 2023 and is estimated to expand at over 7.2% CAGR from 2023 to 2032. STD diagnostics refers to the process of identifying and diagnosing sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs). STD diagnostics involve various tests and procedures aimed at detecting the presence of pathogens, such as bacteria, viruses, parasites, and fungi, that are transmitted through sexual contact. The rising incidence of sexually transmitted diseases (STDs) have become a significant public health concern globally.

To get key market trends

Download Free Sample

For instance, the World Health Organization (WHO) reports over 1 million daily STI cases globally, with most cases being asymptomatic. Annually, about 374 million new infections of curable STIs occur. Thus, as the prevalence of sexually transmitted diseases (STDs) continues to rise globally, there is a growing need for effective management and treatment options such as STD testing and preventive measures.

STD Diagnostics Market Report Attributes
Report Attribute	Details
Base Year:	2023
STD Diagnostics Market Size in 2023:	USD 13.8 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	7.2%
2024 – 2032 Value Projection:	USD 25.7 Billion
Historical Data for:	2018 – 2023
No. of Pages:	389
Tables, Charts & Figures:	525
Segments covered:	Product Type, Test Type, Disease, Technology, End-use, and Region
Growth Drivers:	Rising incidence of sexually transmitted diseases Growing awareness and screening programs Increasing research and development activities Technological advancements in STD diagnostics
Pitfalls & Challenges:	Stigma and sociocultural barriers Stringent regulatory scenario

Learn more about the key segments shaping this market

Download Free Sample

Furthermore, public, and private organizations are significantly investing in research and development efforts to innovate and enhance various in-vitro diagnostics methods which is estimated to reach 141 billion by 2032. These investments stimulate the advancement of new and enhanced diagnostic tools for STDs, such as HIV diagnostics.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of STD diagnostics reached USD 13.8 billion in 2023 and is set to cross USD 25.7 billion by 2032, owing to the rising prevalence of sexually transmitted diseases, and a growing need for effective management & treatment options.

The consumables segment is estimated to surpass USD 18.3 billion by 2032, due to their ability to comprehensive management of STDs by facilitating accurate diagnosis, prompt treatment initiation, preventive measures, and patient education.

North America market accounted for USD 5.6 billion in 2023, backed by a sophisticated healthcare infrastructure, rising prevalence of STDs, rapid technological advancement, and substantial healthcare spending in the region.

Abbott Laboratories, Becton, Dickinson, and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., QIAGEN N.V., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech plc.